Painful prescription - Oct. 10, 2013

Painful prescription - Oct. 10, 2013
Subscribe to Fortune
Home
Video
All Latest Stories
Business News
Companies
Markets
World
My Portfolio
The Buzz
Investing
Fortune 500
Economy
Face to Face
Tech
Personal Finance
Like
CNN
186k
Most Popular
Toyota Prius plug-in drops in price,
amid waning interest
By Katherine Eban @FortuneMagazine October 10, 2013: 8:00 AM ET
277
Leadership
Log In
Video
Painful prescription
Recommend
Small Business
U.S.
1
Email
Print
Kicking the can down the road is not
enough
Unbreakable encryption comes to
the U.S.
Why Delta ordered 11,000 tablets
from Microsoft, not Apple
Corporate cash piles are growing -blame Washington.
(Fortune)
In late 2008, Meridian Health Systems, a nonprofit that owns and
operates six hospitals in southern New Jersey, hired a new
pharmacy benefits management (PBM) company to help reduce
the surging medication costs for its 12,000 employees and their
families. Express Scripts, which has since become the largest
PBM in the country, projected that it would slice at least $763,000
from Meridian's $12 million in annual drug spending.
Hot List
New Cadillac CTS:
American luxury is
back
The 25 highest-paid
men
But just three months into the contract, Meridian discovered that its bills were soaring,
on pace to balloon by $1.3 million in 2009. Express Scripts insisted that, in reality,
Meridian was saving money.
The most powerful
politicos (you don't
yet know)
Robert Schenk didn't buy it. He oversees Meridian's spending on medications for
employees and its in-house pharmacy. Schenk, 57, had once owned two small-town
drugstores but sold them in part because of relentless price-lowering pressure from
PBMs. He knew firsthand how little pharmacies were paid relative to what customers
http://money.cnn.com/2013/10/10/news/companies/pbm-pharma-management.pr.fortune/[10/15/2013 11:09:00 AM]
The Panda-nomics of
China trade
Painful prescription - Oct. 10, 2013
were charged.
Schenk decided to figure out where Meridian's money was going and why its drug
Trading pandas for
uranium
costs were escalating. That was no easy task because, like most PBM customers,
Meridian received data only on what it was being charged for each employee
prescription. Meridian didn't know what it cost the PBM to fill that order.
Then Schenk had a stroke of inspiration. He realized that Meridian had a second
stream of data that almost no other PBM customers had: Its in-house pharmacy was
paid by Express Scripts for many prescriptions. That meant Meridian could see both
Videos You May Like
by Taboola
what the PBM was paying to buy drugs and what it was selling them for.
When he compared the two lists, the mild-mannered pharmacist was shocked: Express
Scripts was making huge gross profits (known as "spreads" in the PBM world) ranging
from $5 per order to many multiples of that. In one particularly extreme example,
Meridian was billed $92.53 for a prescription for generic amoxicillin filled at an outside
Swim in a luxurious
quarry-turned-pool
Never ending woes for
Olive Garden?
What the iPhone 5S
costs Apple
Betsey Johnson still
owning the runway
pharmacy. Meanwhile, Express Scripts paid $26.91 to Meridian's own pharmacy to fill
the same prescription. That meant a spread of $65.62 on one bottle of a generic
antibiotic.
Express Scripts vehemently insists it saves money for clients and that the vast majority
are satisfied with its service. And like any company -- to state the obvious -- it's entitled
to a profit. The question is, Who is making out better -- the PBM or its customers?
Many experts say the former. They argue that many companies stick with traditional
PBMs because drug pricing is so impossible to untangle that customers have no way to
verify how much they're saving, if anything.
Want the full story?
Get FORTUNE the way you want it.
Digital Pass – $2.99
One Year Digital Only – $19.99
One Year ALL ACCESS – JUST $19.99! Best Deal!
Print Magazine + Digital Edition + Subscriber-only content on
FORTUNE.com
If you are already a subscriber, please log in below or sign up below –
i t ti i f !
FORTUNE subscribers login
Need to register
your subscription for
digital access?
(This is different from your CNNMoney login.)
Remember me
password?
SIGN
SIGN IN
IN
Forgot your
Need help?
http://money.cnn.com/2013/10/10/news/companies/pbm-pharma-management.pr.fortune/[10/15/2013 11:09:00 AM]
CNNMoney Sponsors
Painful prescription - Oct. 10, 2013
Join the Conversation
About CNNMoney
Content
Magazines
Site Tools
Stay Connected
Contact Us
Fortune Magazine
Subscribe to Fortune
Site Map
My Account
Advertise with Us
Money Magazine
Subscribe to Money
Watchlist
Mobile Site & Apps
User Preferences
Business News
Give the Gift of Fortune
Portfolio
Facebook
Career Opportunities
Markets
Give the Gift of Money
Job Search
Twitter
Closed Captioning
Term Sheet
Download the Fortune 500
Real Estate Search
LinkedIn
Economy
Reprints
Mortgage and Savings Center
YouTube
Tech
Special Sections
Calculators
RSS Feeds
Personal Finance
Magazine Customer Service
Corrections
Newsletters
Small Business
Conferences
Market Data Alerts
Tumblr
News Alerts
Google+
Video
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR
Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones
Indexes SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes SM © 2013 is proprietary to Dow Jones & Company,
Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved.
Most stock quote data provided by BATS.
© 2013 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy. Ad choices
http://money.cnn.com/2013/10/10/news/companies/pbm-pharma-management.pr.fortune/[10/15/2013 11:09:00 AM]
.